Related Experiment Video
Updated: Nov 29, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Colorectal Cancer Screening in the Elderly
Andrea L Betesh1, Felice H Schnoll-Sussman2
1Department of Gastroenterology and Hepatology, New York-Presbyterian Hospital/Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY 10021, USA.
Colorectal cancer (CRC) screening is recommended for those aged 50-75. For individuals over 75, the benefits of CRC screening may not outweigh the risks due to increased comorbidities and decreased life expectancy.
Area of Science:
- Oncology
- Preventive Medicine
- Geriatrics
Background:
- Colorectal cancer (CRC) is a significant and preventable malignancy.
- Routine screening is advised for average-risk individuals aged 50-75, effectively reducing CRC incidence and mortality.
- The established age cutoff for screening may not adequately address individual health variations.
Purpose of the Study:
- To evaluate the shifting risk-benefit ratio of continued colorectal cancer screening in individuals over 75 years of age.
- To explore the limitations of fixed age cutoffs in guiding personalized screening decisions for older adults.
- To consider the impact of increasing comorbidities and decreasing life expectancy on the efficacy of CRC prevention strategies in the elderly.
Main Methods:
- Review of existing literature on colorectal cancer screening guidelines and outcomes.
- Analysis of risk factors, including age, comorbidities, and life expectancy, in the context of screening.
- Examination of the potential complications associated with colorectal cancer screening procedures.
Main Results:
- The risk-benefit balance for colorectal cancer screening changes significantly after age 75.
- Increased comorbidities and reduced life expectancy in older individuals diminish the future benefits of CRC prevention.
- Screening carries a growing risk of complications in the elderly population.
Conclusions:
- Fixed age cutoffs for colorectal cancer screening are insufficient for making individualized decisions in patients over 75.
- Personalized risk-benefit assessments are crucial for determining the appropriateness of continued screening in older adults.
- Physiological heterogeneity among individuals necessitates a tailored approach to colorectal cancer screening beyond age 75.
More Related Videos
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Endoscopic Procedures II: Colonoscopy
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption